Upgrade to SI Premium - Free Trial

Alterity Therapeutics (ATHE)

2.39 +0.02 (0.84%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 6-K ALTERITY THERAPEUTICS For: Oct 31 October 21, 2026 6:05 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Oct 31 October 21, 2026 6:05 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Oct 31 October 19, 2026 6:04 AM - SEC Filing Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference  October 9, 2026 7:05 AM - Globe NewsWire Form 6-K ALTERITY THERAPEUTICS For: Oct 31 October 9, 2026 6:04 AM - SEC Filing Form 6-K ALTERITY THERAPEUTICS For: Oct 31 October 5, 2026 6:04 AM - SEC Filing Lake Street Starts Alterity Therapeutics (ATHE) at Buy September 15, 2026 7:37 AM - StreetInsider Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy August 11, 2026 7:21 AM - StreetInsider Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update July 30, 2026 7:25 AM - Globe NewsWire Full Article List